Stock Analysis
VRTX - Vertex Pharmaceuticals Incorporated
Disclaimer: The stock analysis which are available on this site represent the personal opinion of their author. There is no warranty of any kind. [Read more]

The following shows the chart price of Vertex Pharmaceuticals Incorporated versus its estimated fair value. The fair value has been estimated using a Discounted Cashflow model (DCF). If the chart value is below the fair value of the stock the stock might be a good buy.

histogram
Market Price: 295.92 $
Fair Value: 57.08 $
Difference: 238.84 $

The chart price of the stock seems to be above the fair value

Last update: 2020-07-09
Year Cashflow Valuation
2005 -189.01 -40.81
2006 -54.89 -47.14
2007 -284.89 -67.72
2008 -258.66 5.22
2009 -451.08 17.64
2010 -673.50 -6.92
2011 109.14 -40.26
2012 196.70 -27.19
2013 -112.06 11.07
2014 -624.31 45.56
2015 -410.73 73.79
2016 179.54 38.73
2017 745.52 43.93
2018 1,174.76 48.74
2019 456.97 52.45
2020 524.12 57.08
2021 591.28 60.90
2022 658.43 65.12
2023 725.58 69.34
Stock Market Explorer - Find undervalued Stocks
Rated 5 / 5 based on 10 reviews

Are you looking for undervalued stocks? Try our stock market explorer to find some.